Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03777657
Brief Title: Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

First Submitted : November 9, 2018
First Submitted that Met QC Criteria : December 14, 2018
First Posted : December 17, 2018

Last Update Submitted that Met QC Criteria : November 12, 2019
Last Update Posted : November 13, 2019